title: [Six-monthly administration of medroxyprogesterone acetate (MPA) (author's transl)].
abstract: For more than six years the authors have studied the acceptability and the effectiveness of Medroxyprogesterone Acetate (450 mg) as a long acting contraceptive (six months). With a Pearl index of 0.85, the method was considered as effective whereas its acceptability was adversely influenced by the bleeding irregularities that take place during the first year of use. A good patient-doctor relationship could lessen this influence.
mesh_terms: D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000008:administration & dosage*; D010817:Physician-Patient Relations
chemical_list: D008525:Medroxyprogesterone
vernacular_title: Administration semestrielle d'acétate de medroxyprogestérone (MPA).